The winds of change are blowing through our energy economy, and it won't be long before they're at gale force. The simple fact is that we can't maintain our prosperity and growth without energy, and we can't continue to produce energy the way we've been doing it all along. Everything about the way we generate, transmit, and consume energy is going to have to change. This creates plenty of investment risk, but it also offers extraordinary opportunity for those who see the big picture.
The cheapest Megawatt
U.S. Deputy Secretary of Energy Daniel Poneman had a lot to say about energy efficiency at the recent Bloomberg New Energy Finance (BNEF) Summit. "Life is too short to work on second-class problems," he said by way of opening. Poneman views the transformation of our energy economy as the challenge of our generation, emphasizing that we cannot resist the transition to sustainability: We must lead it.
The U.S. energy economy has reached 100 quadrillion British thermal units (btu) per year. This is nearly 20% of the world's energy, even though the U.S. has only 5% of the world's population. Astonishingly, more than half the energy we use is wasted. Poneman asks us to think about what we could do with that energy, or with the money saved from not buying it.
Best Clean Energy Companies To Invest In 2015: Skechers U.S.A. Inc.(SKX)
Skechers U.S.A., Inc. engages in the design, development, marketing, and distribution of footwear for men, women, and children in the United States and internationally. The company offers various products comprising casuals, such as boots, shoes, and sandals for men, as well as slip-ons, lug outsole and fashion boots, and casual sandals for women; dress casuals; relaxed fit for men; sandals; and casual fusion under the Skechers USA brand name. It also provides a line of sport footwear for men and women, including men?s lifestyle athletic footwear, lightweight women?s sneakers, and sport sandals under the Skechers Sport brand name. In addition, the company offers men?s and women?s casuals, field boots, hikers, and athletic shoes under the Skechers Work brand name; and a range of infants, toddlers, boys, and girls? boots, shoes, and sneakers under the Skechers Kids brand name. Further, its product line includes Skechers Active products, such as casual everyday and sport fusi on sneakers for females; Tone-ups and Tone-ups Fitness products comprising casual and athletic-inspired sandals for women, as well as sneakers; Shape-ups toning footwear for men and women; and Skechers Resistance Runner technical shoes for runners. Skechers U.S.A. markets its products through department and specialty stores, athletic and independent retailers, and boutiques, catalog and Internet retailers, as well as through own e-commerce Website and retail stores. As of February 15, 2011, it operated 105 concept stores, 99 factory outlet stores, and 40 warehouse outlet stores in the United States, as well as 28 concept stores and 16 factory outlets internationally. The company was founded in 1992 and is headquartered in Manhattan Beach, California.
Advisors' Opinion:- [By John Kell var popups = dojo.query(".socialByline .popC"); popups.forEach(func]
Skechers USA Inc.'s(SKX) first-quarter profit soared as the footwear company reported broad sales growth in the U.S. and abroad, while also striking a bullish tone about demand later this year. The latest period’s results easily topped Wall Street’s expectations. Shares climbed 12% to $41.38 premarket.
- [By Eric Volkman]
Getty Images/Scott Olson The demise of Crocs (CROX), it seems, may have been greatly exaggerated. Remember the company's signature product? Close to a decade ago, those colorful, clunky resin clogs were all the rage. The company that made them couldn't sell the things fast enough, at one point reaching sales of 50 million pairs in 2007. Then fashion moved on, as it always does, and the economic slowdown started to bite into sales. Crocs plunged from a $168 million net profit in 2007 to a $185 million loss in 2008. In 2009, the company nearly ran out of cash and had a hard time making payroll. But Crocs' fortunes have improved. In its most recent quarter, the firm posted a loss, but it was narrower than the market was expecting. And it's found an investor that believes in its future -- private equity giant Blackstone Group (BX), which recently provided a $200 million cash investment in return for a block of preferred shares eventually convertible into a stake of around 13 percent of the company. Perhaps the time has come to take those old clogs out of the closet, dust them off, and slip them on for a stroll. Stepping It Up Fashion is highly susceptible to consumer whim. The hot item is never hot for very long, and once consumers move on, it can be hard for the company to recover. In Crocs' case, this was exacerbated by its limited product line -- almost exclusively the clogs. The company learned from its mistakes. Since consumer tastes moved out of clog-land, Crocs has significantly broadened its product line to 300 styles. It now offers boots, flip-flops, deck shoes and slip-ons akin to the casuals from VF Corp.'s (VFC) Vans subsidiary. In terms of profitability, Crocs recovered quickly from its time in the fashion wilderness. From that 2008 bottom-line deficit of $185 million, the company sliced its loss to $42 million the following year, then stepped back into the black in 2010 (to the tune of $68 million). After two straight years of declines, revenue
Hot Cheapest Companies To Watch In Right Now: The Middleby Corporation (MIDD)
The Middleby Corporation, through its subsidiaries, engages in the design, manufacture, and sale of commercial foodservice and food processing equipment in the United States, Canada, Asia, Europe, the Middle East, and Latin America. The company?s Commercial Foodservice Equipment Group segment manufactures cooking equipment for restaurants and institutional kitchens. Its product line comprises conveyor ovens, ranges, steamers, convection ovens, combi-ovens, broilers and steam cooking equipment, induction cooking systems, baking and proofing ovens, griddles, char broilers, catering equipment, fryers, toasters, hot food servers, food warming equipment, and coffee and beverage dispensing equipment. These products are sold and marketed under the brand names of Anets, Blodgett, Blodgett Combi, Blodgett Range, Bloomfield, CTX, Carter-Hoffmann, CookTek, Doyon, Frifri, Giga, Holman, Houno, Jade, Lang, MagiKitch?n, Middleby Marshall, Nu-Vu, Pitco, PerfectFry, Southbend, Star, Toastm aster, TurboChef, and Wells. In addition, this segment involves in sales, distribution, and export management activities internationally through independent manufacturing representatives and a combined network of independent and company-owned distributors. The Middleby?s Food Processing Equipment Group segment manufactures preparation, cooking, packaging, and food safety equipment for the food processing industry. Its principal products include batch ovens, belt ovens, and conveyorized cooking systems sold under the Alkar brand name; grinding, slicing, emulsification, mixing, and blending products under the Cozzini brand name; breading, battering, mixing, slicing, and forming equipment sold under the MP Equipment brand name; and packaging and food safety equipment sold under the RapidPak brand name. The company was formerly known as Middleby Marshall Oven Company and changed its name to The Middleby Corporation in 1985. The Middleby Corporation was founded in 1888 and is bas ed in Elgin, Illinois.
Advisors' Opinion:- [By Tom Gardner]
In the video interview below, Motley Fool CEO Tom Gardner speaks with Middleby (NASDAQ: MIDD ) CEO Selim Bassoul.�Since becoming CEO in 2000, Bassoul has led a remarkable transformation at Middleby, turning the cooking equipment maker's�stock into a nearly 50-bagger over that time. In the video below, Bassoul discusses how the company can continue its rapid growth.
- [By Jim Jubak]
Take it from someone who has been in and out of Middleby (MIDD) shares over the last decade: the big problem can be finding a way to get back after you've sold because the stock has hit what looks like a peak. (I added Middleby to my Jubak Picks 50 portfolio on May 3 when the shares traded at $144.78. To see the write-up on my annual changes to this portfolio click on this post.)
Hot Cheapest Companies To Watch In Right Now: Expeditors International of Washington Inc.(EXPD)
Expeditors International of Washington, Inc. provides logistics services in the United States and internationally. The company?s services include consolidation or forwarding air and ocean freight; distribution management; vendor consolidation; cargo insurance; purchase order management; and customized logistics information. Its airfreight services comprise the procurement of shipments from its customers; determination of the routing; consolidation of shipments bound for a particular airport distribution point; and selection of the airline for transportation to the distribution point. The company also offers breakbulk services that include receiving and breaking down consolidated airfreight lots and arranging for distribution of the individual shipments. Its ocean freight and ocean services include ocean freight consolidation; and handling full container loads. In addition, the company acts as a customs broker, who assists importers to clear shipments through customs by pre paring required documentation, calculating and providing for payment of duties on behalf of the importer, arranging for any required inspections by governmental agencies, and arranging for delivery; and provides other value added services at destination, such as warehousing and product distribution, time definite transportation, and inventory management. Further, it offers custom clearances for goods moving by rail and truck between the United States, Canada, and/or Mexico; and customs consulting services The company?s customers primarily include retailers, distributors of consumer electronics, department store chains, clothing and shoe wholesalers, manufacturers, and catalogue stores. Expeditors International of Washington, Inc. was founded in 1979 and is based in Seattle, Washington.
Advisors' Opinion:- [By Ben Levisohn]
Like everyone else, Deutsche Bank’s Justin Yagerman starts with his reservations: FedEx has gained 28% during the past three months, trumping the United Parcel Service�� (UPS) 14% advance, the 1.1%rise in�J.B. Hunt Transport Services�(JBHT) and the 3.9% loss in�Expeditors International of Washington�(EXPD).
- [By Ben Levisohn]
The express-delivery company has gained 28% during the past three months, trumping the 18% return from�United Parcel Service�(UPS), the 4.6% gain in J.B. Hunt Transport Services (JBHT) and the 0.2% rise in Expeditors International of Washington�(EXPD).
Hot Cheapest Companies To Watch In Right Now: Seattle Genetics Inc.(SGEN)
Seattle Genetics, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases in the United States. Its lead product, SGN-35 is in pivotal trial stage used for the treatment of patients with relapsed or refractory hodgkin lymphoma. The company?s other product candidates in various stages of clinical trials include SGN-75, which is in Phase I clinical trials for metastatic renal cell carcinoma and non-Hodgkin lymphoma; ASG-5ME, a preclinical antibody-drug conjugate product candidate for the treatment of solid tumors; dacetuzumab (SGN-40), a humanized anti-CD40 antibody; SGN-70, a humanized anti-CD70 antibody for the treatment of autoimmune diseases; and SGN-19A, a preclinical antibody-drug conjugate product candidate for the treatment of hematologic malignancies. It has collaborations with Bayer Pharmaceuticals Corporation; Celldex Therapeutics, Inc .; Daiichi Sankyo Co., Ltd.; Genentech, Inc.; GlaxoSmithKline LLC; Millennium; and PSMA Development Company LLC. The company also has an antibody-drug conjugates co-development agreement with Agensys, Inc.; and Genmab A/S. Seattle Genetics, Inc. was founded in 1997 and is headquartered in Bothell, Washington.
Advisors' Opinion:- [By Henry Kawabe]
A number of analysts believe the stock of the biotech company Seattle Genetics (SGEN) has risen too high too quickly to support its current price, and have issued much lower target prices on the stocks than where it currently sits. On Thursday August 1st, Analysts at Cantor Fitzgerald issued a target price of $24 a share with a "sell" recommendation as they see the potential downside of the stock could drop 40.77% from its July 31st close. Previously, on June 10th, Zacks downgraded the stock and placed a price target of $41.20 per share. In May, analysts at UBS AG issued a price target from $30.00 to $36.00 giving the stock a "neutral" rating, while analysts at Leerink Swann issued a price target of $42.00. So far, the analysts have been wrong as Seattle Genetics has blown past their price targets, and as of August 2nd, the stock continued to rise, closing at $43.28 per share.
- [By Brian Orelli]
It's certainly in the FDA's right to ask outside experts for their opinion; I would argue it's not all that surprising even if the FDA is leaning strongly toward approving the drug. There are plenty of cases --�Seattle Genetics' (NASDAQ: SGEN ) Adcetris,�for example�--�where the FDA called a meeting only to gush all over the drug. The drug got a unanimous positive recommendation from the panel and was approved early by the FDA.
No comments:
Post a Comment